China Anti Aging Therapeutics Market Analysis

China Anti Aging Therapeutics Market Analysis


$ 3999

China's anti-aging therapeutics market is projected to grow from $49 Mn in 2022 to $183 Mn in 2030 with a CAGR of 18.03% for the year 2022-30. As China has the fastest-growing elderly population in the world, the market is projected to expand during the forecast period. Further, the concerns over the appearance of social media among the young Chinese population are also responsible for the growth of the market. The China anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the top players in the market include Harbour BioMed, Hua Medicine, and Rejuvenate Bio.

ID: IN10CNPH030 CATEGORY: Pharmaceuticals GEOGRAPHY: China AUTHOR: Parul Choudhary

Buy Now

China Anti-Aging Therapeutics Market Executive Summary

China's anti-aging therapeutics market size is at around $49 Mn in 2022 and is projected to reach $183 Mn in 2030, exhibiting a CAGR of 18.03% during the forecast period. According to the South China Morning Post's most recent healthcare report, China's combined pharmaceutical and biopharma R&D expenditure will increase at a compound annual rate of 23% until 2023, reaching $49 Bn. By then, 23% of the global total for drug finding and testing will be spent on pharmaceutical and biopharma R&D in China. By 2021, sales of biopharmaceuticals in China are expected to nearly double from their 2016 level to $50 Bn. Before 2030, the SCMP research found that China could be on par with America and Europe in terms of its ability to produce best-in-class medications. China's healthcare market was the second-largest in the world in 2018, spending $3.5 trillion in that sector.

Aging is the negative change in an organism's overall function that happens as it gets older. The theory of genetic mutation, telomere loss, somatic mutation, free radical damage, immune disorder, mitochondrial dysfunction, and autophagy dysfunction are some of the biological processes that contribute to the highly complex biological process of aging. Despite China's longstanding reputation as a nation that values and honors its elders, the country is currently experiencing a surge in anti-aging initiatives. All groups exhibit enthusiasm for anti-aging products, according to observers. For the first time, a novel cause of cellular senescence has been discovered using a genome-wide CRISPR-based screening technique. According to Chinese experts, it can be incorporated into novel ways to postpone aging and ward off diseases linked to it. The study team showed that knocking out, or disabling, some genes by CRISPR can prevent the aging of human mesenchymal precursor cells by screening and finding more than 100 genes responsible for the aging of human cells. (hMPCs). KAT7 (a histone acetyltransferase) is one of the senility-causing genes and a key factor in aging. The innovative gene therapy, which depends on turning off a specific gene or using KAT7 inhibitors, could potentially extend the lives of mammals. Furthermore, it might delay the deterioration of human liver cells. It implies a significant possibility for its use in translational medicine to combat human aging.

 

China Anti Aging Therapeutics Market

Market Dynamics

Market Growth Drivers Analysis

One factor influencing the market is the rising concern in China about how one appears on social media. China's aging population, which is one of the fastest-growing in the world, is one of the factors further igniting this anti-aging trend, according to WHO. Because of the differences in culture and society, these groups are more ready than their western counterparts to invest time, money, and effort into maintaining a youthful appearance. The China anti-aging therapeutics market's expansion is also due to social media and e-commerce. To capitalize on this generation's potential for online shopping, Alibaba launched its "Taobao for Elders" initiative at the beginning of 2018. The online lifestyle community Xiaohongshu, also known as "Little Red Book," is well-recognized and caters to young people in China. With the recent debut of Laohongshu (literally, "Old Red Book"), it began to include the elderly.

In the anti-aging market, personalized care-focused AI is commonly seen in technical R&D and client-focused marketing. Fermentation and synthetic biotechnology, in particular, are currently the China anti-aging therapeutics market's star components and are of natural or biotechnological origin.

Market Restraints

Companies seeking to market new anti-aging therapies in China may find the regulatory environment to be complicated and difficult. Delays and higher expenses for businesses may result from this, which may deter market innovation and investment. China has a long tradition of using traditional Chinese medicine, and it is still widely practiced today. Modern anti-aging treatments may not always be preferred by patients, which could impede the China anti-aging therapeutics market's expansion.

Competitive Landscape

Key Players

  • BeiGene (CHN)
  • Chi-Med (CHN)
  • CStone Pharmaceuticals (CHN)
  • Harbour BioMed (CHN)
  • Hua Medicine (CHN)
  • Rejuvenate Bio
  • Rejenevie Therapeutics
  • MyMD Pharmaceuticals
  • Intervene Immune
  • CohBar

Healthcare Policies and Regulatory Landscape

The National Medical Products Administration (NMPA), formerly known as the China Food and Drug Administration, is the regulatory body in charge of overseeing the licensing and control of anti-aging medications in China. (CFDA). In China, the NMPA is in charge of regulating all pharmaceutical goods, including anti-aging medications. Before pharmaceutical goods are permitted for sale in China, the agency is in charge of assessing their quality, safety, and efficacy. Clinical trial requirements, product registration requirements, and post-market surveillance requirements are all part of the complete regulatory framework for pharmaceutical products that the NMPA has put in place. Before their products can be sold in the Chinese market, businesses looking to develop and market anti-aging drugs in China must abide by these rules and receive approval from the NMPA. For patients in China, the NMPA has lately improved access to modern treatments by streamlining the drug approval procedure. These adjustments include accelerated review processes for specific drug classes as well as modifications to the clinical trial specifications for specific drugs.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Anti-Aging Therapeutics Market Segmentation

By Product (Revenue, USD Billion):

  • Anti-Wrinkle
  • Hair Color
  • Ultraviolet (UV) Absorption
  • Anti-Stretch Mark
  • Others

By Treatment (Revenue, USD Billion):

  • Hair Restoration
  • Anti-Pigmentation
  • Adult Acne Therapy
  • Breast Augmentation
  • Liposuction
  • Chemical Peel
  • Others

By Target Group (Revenue, USD Billion):

  • Male
  • Female

By Type of Aging (Revenue, USD Billion):

  • Cellular Aging
  • Immune Aging
  • Metabolic Aging
  • Others

By Type of Molecules (Revenue, USD Billion):

  • Biologics
  • Small Molecules

By Mechanism of Action (Revenue, USD Billion):

  • Senolytic
  • Cell Regeneration
  • mTOR inhibitor/Modulator
  • AMP-kinase/AMP Activator
  • Mitochondria Inhibitor/Modulator
  • Others

By Ingredient (Revenue, USD Billion):

  • Retinoid
  • Hyaluronic Acid
  • Alpha Hydroxy Acid
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Pharmacies
  • Stores
  • Online Stores

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 05 December 2023
Updated by: Shivam Zalke

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up